iridium radioisotopes has been researched along with Rectal Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T; Isohashi, F; Koizumi, M; Konishi, K; Kotsuma, T; Ogata, T; Sumida, I; Suzuki, O; Takahashi, Y; Yoshioka, Y | 1 |
| Chang, WC; Chen, SW; Hung, YC; Liang, JA; Lin, FJ; Lin, WC; Shiau, AC; Yang, SN; Yeh, LS; Yu, CY | 1 |
| Kamada, T; Kato, S; Kiyohara, H; Nakano, T; Ohkubo, Y; Ohno, T; Tran, DN | 1 |
| Akimoto, T; Harada, K; Katoh, H; Kitamoto, Y; Nakano, T; Shirai, K; Tamaki, T | 1 |
| Dubray, BM; Thames, HD | 1 |
5 other study(ies) available for iridium radioisotopes and Rectal Diseases
| Article | Year |
|---|---|
Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Middle Aged; Radiation Injuries; Rectal Diseases; Rectum; Relative Biological Effectiveness; Uterine Cervical Neoplasms | 2010 |
Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brachytherapy; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiation Injuries; Radiotherapy Dosage; Rectal Diseases; Risk Factors; Urinary Bladder Diseases; Uterine Cervical Neoplasms | 2010 |
CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Imaging, Three-Dimensional; Iridium Radioisotopes; Middle Aged; Organ Size; Radiation Injuries; Radiation Protection; Radiometry; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Diseases; Rectum; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Brachytherapy; Dose Fractionation, Radiation; Gastrointestinal Hemorrhage; Humans; Iridium Radioisotopes; Male; Middle Aged; Prostatic Neoplasms; Radiation Injuries; Rectal Diseases; Rectum | 2006 |
Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.
Topics: Algorithms; Animals; Brachytherapy; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; Female; Iridium Radioisotopes; Likelihood Functions; Models, Statistical; Radiation Dosage; Radiation Injuries, Experimental; Radiation Tolerance; Rats; Rats, Wistar; Rectal Diseases; Rectum; Time Factors; Tissue Survival; Wound Healing | 1994 |